Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight (Aaron Weitzman/Axios)
Main Link | Techmeme Permalink
Main Link | Techmeme Permalink
May 17, 2025 at 5:31 AM
Boston-based PhaseV, which is developing AI software to accelerate clinical trials and drug development, raised a $50M Series A co-led by Accel and Insight (Aaron Weitzman/Axios)
Main Link | Techmeme Permalink
Main Link | Techmeme Permalink
PhaseV Collaborates with Toronto's UHN to Transform Lupus Research Through Machine Learning#Canada#Toronto#PhaseV#Lupus#UHN
PhaseV Collaborates with Toronto's UHN to Transform Lupus Research Through Machine Learning
PhaseV and University Health Network join forces, applying machine learning to improve understanding and treatment of lupus, a complex autoimmune disease.
third-news.com
January 16, 2025 at 2:08 PM
PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026#United_States#Boston#Clinical_Trials#PhaseV#AI/ML
PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026
PhaseV is set to showcase its innovative AI/ML solutions at key conferences in 2026, aiming to enhance clinical trial efficiency and patient outcomes.
third-news.com
March 26, 2026 at 12:57 PM
PhaseV Introduces Integrated AI Solutions to Revolutionize Clinical Trials in 2026#United_States#Boston#Clinical_Trials#PhaseV#AI/ML
AI is reshaping drug discovery and clinical trials, prompting the FDA to weigh new patient safety rules. Firms like PhaseV and BioPhy use AI for precise patient matching and trial diversity, enhancing efficiency but narrowing commercial reach. 🩺🖥️ #MLSky 💊
How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery
While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.
observer.com
November 14, 2024 at 4:18 PM
AI is reshaping drug discovery and clinical trials, prompting the FDA to weigh new patient safety rules. Firms like PhaseV and BioPhy use AI for precise patient matching and trial diversity, enhancing efficiency but narrowing commercial reach. 🩺🖥️ #MLSky 💊
New partnership between PhaseV and Crohn’s & Colitis Foundation leverages #AI and #RWD to transform #IBD trials | Becaris Publishing becarispublishing.com/digital-cont...
New partnership between PhaseV and Crohn’s & Colitis Foundation leverages AI and RWD to transform IBD trials | Becaris Publishing
becarispublishing.com
June 2, 2025 at 10:27 AM
New partnership between PhaseV and Crohn’s & Colitis Foundation leverages #AI and #RWD to transform #IBD trials | Becaris Publishing becarispublishing.com/digital-cont...
PhaseV Strengthens Leadership with Biopharma Experts Klaus Beck and Avi Kulkarni for AI Development#United_States#Boston#PhaseV#Avi_Kulkarni#Klaus_Beck
PhaseV Strengthens Leadership with Biopharma Experts Klaus Beck and Avi Kulkarni for AI Development
PhaseV has appointed Klaus Beck and Avi Kulkarni to its Scientific Advisory Board, aiming to enhance the AI Conductor platform for clinical development.
third-news.com
September 16, 2026 at 12:35 PM
PhaseV Strengthens Leadership with Biopharma Experts Klaus Beck and Avi Kulkarni for AI Development#United_States#Boston#PhaseV#Avi_Kulkarni#Klaus_Beck
Thoughts on this? >> PhaseV to Showcase New AI/ML-Powered Clinical Trial Design
and Analysis Capabilities at CMO Summit 360⁰: Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive… >> Comment below! #AI #IoT #mhealth #industry40 #healthtech
and Analysis Capabilities at CMO Summit 360⁰: Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive… >> Comment below! #AI #IoT #mhealth #industry40 #healthtech
PhaseV to Showcase New AI/ML-Powered Clinical Trial Design
and Analysis Capabilities at CMO Summit 360⁰
Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive Analysis for Clinical Trial Success BOSTON, March 24, 2025 /PRNewswire/ — PhaseV, a leader in AI/ML-driven clinical development, announced today that it will demonstrate new capabilities of its platform for clinical trials at the upcoming Chief Medical Officer (CMO) …
dlvr.it
March 24, 2025 at 1:11 PM
Thoughts on this? >> PhaseV to Showcase New AI/ML-Powered Clinical Trial Design
and Analysis Capabilities at CMO Summit 360⁰: Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive… >> Comment below! #AI #IoT #mhealth #industry40 #healthtech
and Analysis Capabilities at CMO Summit 360⁰: Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive… >> Comment below! #AI #IoT #mhealth #industry40 #healthtech
Seven Leading Pharmaceutical Firms Embrace PhaseV's Advanced ML Tools for Drug Development Success#USA#Boston#PhaseV#Machine_Learning#Drug_Development
Seven Leading Pharmaceutical Firms Embrace PhaseV's Advanced ML Tools for Drug Development Success
Seven global pharmaceutical companies are utilizing PhaseV's machine learning technologies to revolutionize drug development processes in various therapeutic areas.
third-news.com
November 25, 2024 at 1:37 PM
Seven Leading Pharmaceutical Firms Embrace PhaseV's Advanced ML Tools for Drug Development Success#USA#Boston#PhaseV#Machine_Learning#Drug_Development
The #JSM2025 Spotlight in the EXPO is hopping today. The Coffee House opens at 10:00 a.m. for both coffee and tea. At 1:30 p.m., pick up a tasty bag of popcorn, then head back over at 3:30 p.m. for a microbrew (while supplies last). Cheers to PhaseV Trials for their sponsorship. #statssky
August 4, 2025 at 2:35 PM
The Wrong Unit of Work: What Happened When I Built My Dev Environment using Claude Code
via Dev.to
https://flarestart.com/article/the-wrong-unit-of-work-what-happened-when-i-built-my-dev-environment-using-claude-code-20260303
#DevNews #DevOps #Tutorial
via Dev.to
https://flarestart.com/article/the-wrong-unit-of-work-what-happened-when-i-built-my-dev-environment-using-claude-code-20260303
#DevNews #DevOps #Tutorial
The Wrong Unit of Work: What Happened When I Built My Dev Environment using Claude Code
I use Claude Code daily for real product engineering. I'm building a clinical trials platform at PhaseV, and Claude Code is my primary coding partner across a multi-repo microservices stack. Recently...
flarestart.com
March 3, 2026 at 9:29 PM
The Wrong Unit of Work: What Happened When I Built My Dev Environment using Claude Code
via Dev.to
https://flarestart.com/article/the-wrong-unit-of-work-what-happened-when-i-built-my-dev-environment-using-claude-code-20260303
#DevNews #DevOps #Tutorial
via Dev.to
https://flarestart.com/article/the-wrong-unit-of-work-what-happened-when-i-built-my-dev-environment-using-claude-code-20260303
#DevNews #DevOps #Tutorial
ガチャも軽傷で済んだしPhaseVもクリア出来てほくほく
August 24, 2026 at 11:05 AM
ガチャも軽傷で済んだしPhaseVもクリア出来てほくほく
New PhaseV Survey Highlights Operational Delays in Clinical Trials Impacting Pharmaceutical Development#USA#Boston#Clinical_Trials#PhaseV#AI_Conductor
New PhaseV Survey Highlights Operational Delays in Clinical Trials Impacting Pharmaceutical Development
A recent PhaseV survey reveals alarming delays in clinical trial processes, with 88% of sponsors facing five or more weeks due to vendor fragmentation. This highlights a crucial need for automation.
third-news.com
August 17, 2026 at 12:45 PM
New PhaseV Survey Highlights Operational Delays in Clinical Trials Impacting Pharmaceutical Development#USA#Boston#Clinical_Trials#PhaseV#AI_Conductor
Head to the EXPO for JSM Spotlight treats & activities: Coffee House at 10 a.m.; Photo Booth, sponsored by SAS, from 11 a.m. to 2 p.m.; New England Cheese at 1 p.m.; and Microbrew Tasting, sponsored by PhaseV Trials, at 3:30 p.m. (while supplies last). tinyurl.com/r3x7pyry #JSM2026 #STATSSKY
August 3, 2026 at 1:24 PM
Head to the EXPO for JSM Spotlight treats & activities: Coffee House at 10 a.m.; Photo Booth, sponsored by SAS, from 11 a.m. to 2 p.m.; New England Cheese at 1 p.m.; and Microbrew Tasting, sponsored by PhaseV Trials, at 3:30 p.m. (while supplies last). tinyurl.com/r3x7pyry #JSM2026 #STATSSKY
PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients #healthIT #PhaseV
www.healthcareittoday.com/?p=2523772
www.healthcareittoday.com/?p=2523772
June 6, 2025 at 6:00 PM
PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients #healthIT #PhaseV
www.healthcareittoday.com/?p=2523772
www.healthcareittoday.com/?p=2523772
PhaseV unveiled Enrollment Lab, adding AI-powered enrollment modeling to its ClinOps platform to quantify real-world patient access. #DataScience #AI #ArtificialIntelliigence opendatascience.com/phasev-launc...
PhaseV Launches Enrollment Lab to Model Trial Enrollment Before Protocol Lock
PhaseV has launched Enrollment Lab, a new AI-powered solution designed to quantify a clinical study’s enrollment potential and model protocol trade-offs earlier in planning—before protocol lock and pr...
opendatascience.com
February 19, 2026 at 12:15 PM
PhaseV unveiled Enrollment Lab, adding AI-powered enrollment modeling to its ClinOps platform to quantify real-world patient access. #DataScience #AI #ArtificialIntelliigence opendatascience.com/phasev-launc...
PhaseV unveiled Enrollment Lab, adding AI-powered enrollment modeling to its ClinOps platform to quantify real-world patient access. #DataScience #AI #ArtificialIntelliigence opendatascience.com/phasev-launc...
PhaseV Launches Enrollment Lab to Model Trial Enrollment Before Protocol Lock
PhaseV has launched Enrollment Lab, a new AI-powered solution designed to quantify a clinical study’s enrollment potential and model protocol trade-offs earlier in planning—before protocol lock and pr...
opendatascience.com
February 10, 2026 at 10:19 AM
PhaseV unveiled Enrollment Lab, adding AI-powered enrollment modeling to its ClinOps platform to quantify real-world patient access. #DataScience #AI #ArtificialIntelliigence opendatascience.com/phasev-launc...